Prosecution Insights
Last updated: August 16, 2026
Application No. 18/794,038

Composition Comprising Hueing Agent

Non-Final OA §DP
Filed
Aug 05, 2024
Priority
Mar 02, 2020 — provisional 62/983,873 +2 more
Examiner
ELHILO, EISA B
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
MILLIKEN & Company
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1206 granted / 1451 resolved
+18.1% vs TC avg
Strong +16% interview lift
Without
With
+16.0%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 9m
Avg Prosecution
34 currently pending
Career history
1472
Total Applications
across all art units

Statute-Specific Performance

§101
2.7%
-37.3% vs TC avg
§103
39.8%
-0.2% vs TC avg
§102
18.8%
-21.2% vs TC avg
§112
24.0%
-16.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1451 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status 1 The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2 This action is responsive to the applicant’s election without traverse received by the office on June 22, 2026. Election of claims 1-2 and 6 is acknowledged. Claims 3-5 and 7-8 are withdrawn from further consideration by the examiner, 37 CFR 1.142(b), as being drawn to a non-elected invention. Therefore, claims 1-2 and 6 are pending in this application. Double Patenting 3 The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-2 and 6 rejected on the ground of nonstatutory double patenting as being unpatentable over claims of U.S. Patent No. 11,718,814 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the claims of the U.S. Patent No. 11,718,814 B2 teach a laundry care composition for textile article, and wherein the laundry care composition comprises a polymeric thiophene hueing agent having the structure of a formula III and formula Y which are similar to the claimed formulae (1) and (x) and each in the claimed amounts as claimed in claim 1 (see col. 44, formulae III and Y) and wherein the laundry care composition also comprises compounds having structures similar to those claimed in claim 1 (see claim 11) and wherein the textile article is comprised of cellulose-containing fiber as claimed in claims 2 and 6 (see claim 14). Therefore, this is an obvious formulation. Claims 1-2 and 6 rejected on the ground of nonstatutory double patenting as being unpatentable over claims of U.S. Patent No. 12,209,231 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the claims of the U.S. Patent No. 12,209,231 B2 teach a laundry care composition for textile article, and wherein the laundry care composition comprises a polymeric thiophene hueing agent having the structure of a formula III and formula Y which are similar to the claimed formulae (1) and (x) and each in the claimed amounts as claimed in claim 1 (see col. 44, formulae III and Y) and wherein the laundry care composition also comprises compounds having structures similar to those claimed in claim 1 (see claim 2) and wherein the textile article is comprised of cellulose-containing fiber as claimed in claims 2 and 6 (see claim 10). Therefore, this is an obvious formulation. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to EISA B ELHILO whose telephone number is (571)272-1315. The examiner can normally be reached Monday-Friday, 7:00 AM to 3:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at (571)272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EISA B ELHILO/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Aug 05, 2024
Application Filed
Jul 17, 2026
Non-Final Rejection mailed — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12698456
N-SUBSTITUTED 2-(6-HYDROXY-3-OXO-3H-XANTHENE-9-YL)BENZAMIDES AS PHOTOACTIVATORS IN DETERGENTS
2y 8m to grant Granted Aug 04, 2026
Patent 12692461
Composite Form of Tetraacetylenediamine
3y 4m to grant Granted Jul 28, 2026
Patent 12692463
BLENDS OF ALCOHOL ETHOXYLATE AND METHYL ESTER SULFONATE IN UNIT DOSE PRODUCTS FOR IMPROVED MILDNESS
2y 9m to grant Granted Jul 28, 2026
Patent 12692457
SOLAR PANEL CLEANING FORMULATION
2y 2m to grant Granted Jul 28, 2026
Patent 12685704
MULTIPHASE CLEANSING COMPOSITION
2y 7m to grant Granted Jul 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+16.0%)
1y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1451 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month